Aster Biofabrication offers automated instrumentation for precise and reproducible 3D cell culture and bioprinting. Our platform enhances throughput and reduces variability in cellular construct fabrication, accelerating research in drug discovery and tissue engineering.
Funding
Funding not disclosed
Founders
Product
Problem
Current 3D cell culture workflows, particularly in bioprinting and tissue engineering, face challenges with automation and reproducibility. This limits the efficiency of research and development in areas like drug discovery and regenerative medicine.
Solution
Aster Biofabrication provides automated instrumentation designed to enhance the precision and throughput of 3D cell culture applications. Our platform addresses the inherent variability in manual cell handling and deposition, enabling researchers to achieve more consistent and reliable experimental outcomes. By integrating advanced robotics and control systems, we facilitate the creation of complex cellular constructs with greater fidelity. This automation accelerates the pace of discovery and the development of novel therapeutic strategies.
Target Audience
Our primary customers are academic research institutions and biotechnology companies engaged in cell-based assays, drug screening, and tissue engineering research.
Features
- Automated cell dispensing system with sub-micron precision for precise spheroid and tissue construct fabrication.
- Integrated environmental control (temperature, humidity, CO2) to maintain optimal cell viability during culture and printing.
- Modular hardware architecture allowing for customization with various bio-inks and cell types.
- Real-time process monitoring with optical feedback for quality control and data logging.
- Software interface for defining complex 3D printing paths and cell seeding patterns.
- Compatibility with standard laboratory consumables and cell culture media.